LCA5
1 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| Safety and Tolerability Subretinal OPGx-001 for LCA5-Associated Inherited Retinal Degeneration (LCA5-IRD) and Non-interventional Arm With Untreated Patients (NCT05616793) | Opus Genetics, Inc | 2023-06-15 |
Track LCA5 automatically
Every clearance here is in the API, with alerts when new ones post.